Zinc in PDB 5l0k: Crystal Structure of Autotaxin and Compound Pf-8380
Enzymatic activity of Crystal Structure of Autotaxin and Compound Pf-8380
All present enzymatic activity of Crystal Structure of Autotaxin and Compound Pf-8380:
3.1.4.39;
Protein crystallography data
The structure of Crystal Structure of Autotaxin and Compound Pf-8380, PDB code: 5l0k
was solved by
J.D.Durbin,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
96.23 /
2.73
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
95.924,
121.422,
156.247,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
22.6 /
27
|
Other elements in 5l0k:
The structure of Crystal Structure of Autotaxin and Compound Pf-8380 also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Autotaxin and Compound Pf-8380
(pdb code 5l0k). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total 4 binding sites of Zinc where determined in the
Crystal Structure of Autotaxin and Compound Pf-8380, PDB code: 5l0k:
Jump to Zinc binding site number:
1;
2;
3;
4;
Zinc binding site 1 out
of 4 in 5l0k
Go back to
Zinc Binding Sites List in 5l0k
Zinc binding site 1 out
of 4 in the Crystal Structure of Autotaxin and Compound Pf-8380
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 1 of Crystal Structure of Autotaxin and Compound Pf-8380 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn903
b:37.8
occ:1.00
|
NE2
|
A:HIS315
|
2.1
|
34.4
|
1.0
|
N31
|
A:6ZO906
|
2.1
|
51.7
|
1.0
|
NE2
|
A:HIS474
|
2.1
|
30.2
|
1.0
|
OD1
|
A:ASP311
|
2.2
|
33.7
|
1.0
|
OD2
|
A:ASP311
|
2.6
|
32.7
|
1.0
|
CG
|
A:ASP311
|
2.7
|
34.3
|
1.0
|
CE1
|
A:HIS315
|
3.0
|
36.2
|
1.0
|
CD2
|
A:HIS474
|
3.1
|
31.1
|
1.0
|
C30
|
A:6ZO906
|
3.1
|
54.8
|
1.0
|
CD2
|
A:HIS315
|
3.1
|
35.6
|
1.0
|
CE1
|
A:HIS474
|
3.1
|
29.4
|
1.0
|
C28
|
A:6ZO906
|
3.2
|
54.4
|
1.0
|
O32
|
A:6ZO906
|
3.3
|
55.0
|
1.0
|
C27
|
A:6ZO906
|
3.7
|
54.4
|
1.0
|
ND1
|
A:HIS315
|
4.1
|
35.7
|
1.0
|
CB
|
A:ASP311
|
4.2
|
34.2
|
1.0
|
OG1
|
A:THR209
|
4.2
|
36.1
|
1.0
|
CG
|
A:HIS474
|
4.2
|
30.7
|
1.0
|
ND1
|
A:HIS474
|
4.2
|
29.3
|
1.0
|
CG
|
A:HIS315
|
4.2
|
36.3
|
1.0
|
C26
|
A:6ZO906
|
4.3
|
55.1
|
1.0
|
CE1
|
A:HIS359
|
4.3
|
25.5
|
1.0
|
O29
|
A:6ZO906
|
4.3
|
54.2
|
1.0
|
ZN
|
A:ZN904
|
4.4
|
54.4
|
1.0
|
NE2
|
A:HIS359
|
4.5
|
27.5
|
1.0
|
OD1
|
A:ASP171
|
4.6
|
36.8
|
1.0
|
O
|
A:HOH1027
|
4.6
|
37.4
|
1.0
|
CE
|
A:MET361
|
4.8
|
35.3
|
1.0
|
|
Zinc binding site 2 out
of 4 in 5l0k
Go back to
Zinc Binding Sites List in 5l0k
Zinc binding site 2 out
of 4 in the Crystal Structure of Autotaxin and Compound Pf-8380
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 2 of Crystal Structure of Autotaxin and Compound Pf-8380 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Zn904
b:54.4
occ:1.00
|
OD1
|
A:ASP171
|
2.1
|
36.8
|
1.0
|
NE2
|
A:HIS359
|
2.1
|
27.5
|
1.0
|
OG1
|
A:THR209
|
2.3
|
36.1
|
1.0
|
OD2
|
A:ASP358
|
2.3
|
31.1
|
1.0
|
CG
|
A:ASP171
|
2.8
|
35.2
|
1.0
|
OD2
|
A:ASP171
|
2.9
|
40.2
|
1.0
|
CB
|
A:THR209
|
3.0
|
33.4
|
1.0
|
CE1
|
A:HIS359
|
3.0
|
25.5
|
1.0
|
CD2
|
A:HIS359
|
3.1
|
25.2
|
1.0
|
CA
|
A:THR209
|
3.1
|
33.1
|
1.0
|
CG
|
A:ASP358
|
3.2
|
31.5
|
1.0
|
CG2
|
A:THR209
|
3.2
|
30.9
|
1.0
|
OD1
|
A:ASP358
|
3.5
|
33.4
|
1.0
|
N
|
A:THR209
|
3.6
|
32.9
|
1.0
|
C27
|
A:6ZO906
|
4.0
|
54.4
|
1.0
|
ND1
|
A:HIS359
|
4.1
|
26.4
|
1.0
|
CG
|
A:HIS359
|
4.1
|
26.3
|
1.0
|
CB
|
A:ASP171
|
4.2
|
33.4
|
1.0
|
CE1
|
A:HIS474
|
4.2
|
29.4
|
1.0
|
OD1
|
A:ASP311
|
4.3
|
33.7
|
1.0
|
N
|
A:GLY172
|
4.3
|
30.4
|
1.0
|
NE2
|
A:HIS474
|
4.4
|
30.2
|
1.0
|
CB
|
A:ASP358
|
4.4
|
29.2
|
1.0
|
C
|
A:LYS208
|
4.4
|
32.5
|
1.0
|
ZN
|
A:ZN903
|
4.4
|
37.8
|
1.0
|
C
|
A:THR209
|
4.5
|
33.4
|
1.0
|
CG
|
A:ASP311
|
4.5
|
34.3
|
1.0
|
CA
|
A:ASP171
|
4.6
|
33.0
|
1.0
|
C28
|
A:6ZO906
|
4.6
|
54.4
|
1.0
|
N31
|
A:6ZO906
|
4.7
|
51.7
|
1.0
|
C
|
A:ASP171
|
4.8
|
31.5
|
1.0
|
C25
|
A:6ZO906
|
4.8
|
54.9
|
1.0
|
O
|
A:THR209
|
4.9
|
33.8
|
1.0
|
OD2
|
A:ASP311
|
4.9
|
32.7
|
1.0
|
O
|
A:LYS208
|
5.0
|
32.2
|
1.0
|
CB
|
A:ASP311
|
5.0
|
34.2
|
1.0
|
|
Zinc binding site 3 out
of 4 in 5l0k
Go back to
Zinc Binding Sites List in 5l0k
Zinc binding site 3 out
of 4 in the Crystal Structure of Autotaxin and Compound Pf-8380
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 3 of Crystal Structure of Autotaxin and Compound Pf-8380 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn904
b:37.5
occ:1.00
|
NE2
|
B:HIS474
|
2.0
|
29.7
|
1.0
|
NE2
|
B:HIS315
|
2.1
|
39.2
|
1.0
|
N31
|
B:6ZO907
|
2.1
|
58.0
|
1.0
|
OD1
|
B:ASP311
|
2.3
|
36.2
|
1.0
|
OD2
|
B:ASP311
|
2.4
|
35.4
|
1.0
|
CG
|
B:ASP311
|
2.7
|
38.3
|
1.0
|
CE1
|
B:HIS474
|
3.0
|
31.1
|
1.0
|
CE1
|
B:HIS315
|
3.1
|
41.1
|
1.0
|
CD2
|
B:HIS474
|
3.1
|
29.7
|
1.0
|
CD2
|
B:HIS315
|
3.1
|
41.7
|
1.0
|
C28
|
B:6ZO907
|
3.1
|
61.8
|
1.0
|
C30
|
B:6ZO907
|
3.2
|
61.2
|
1.0
|
O32
|
B:6ZO907
|
3.4
|
61.5
|
1.0
|
C27
|
B:6ZO907
|
3.5
|
61.0
|
1.0
|
ND1
|
B:HIS474
|
4.1
|
32.3
|
1.0
|
CB
|
B:ASP311
|
4.2
|
37.4
|
1.0
|
CG
|
B:HIS474
|
4.2
|
32.5
|
1.0
|
ND1
|
B:HIS315
|
4.2
|
41.2
|
1.0
|
CG
|
B:HIS315
|
4.3
|
41.1
|
1.0
|
C26
|
B:6ZO907
|
4.3
|
62.7
|
1.0
|
OG1
|
B:THR209
|
4.3
|
38.9
|
1.0
|
CE1
|
B:HIS359
|
4.3
|
28.0
|
1.0
|
O29
|
B:6ZO907
|
4.4
|
63.4
|
1.0
|
OD2
|
B:ASP171
|
4.5
|
38.7
|
1.0
|
ZN
|
B:ZN905
|
4.5
|
63.6
|
1.0
|
NE2
|
B:HIS359
|
4.5
|
26.2
|
1.0
|
CE
|
B:MET361
|
4.7
|
39.3
|
1.0
|
C25
|
B:6ZO907
|
4.9
|
60.7
|
1.0
|
|
Zinc binding site 4 out
of 4 in 5l0k
Go back to
Zinc Binding Sites List in 5l0k
Zinc binding site 4 out
of 4 in the Crystal Structure of Autotaxin and Compound Pf-8380
Mono view
Stereo pair view
|
A full contact list of Zinc with other atoms in the Zn binding
site number 4 of Crystal Structure of Autotaxin and Compound Pf-8380 within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:Zn905
b:63.6
occ:1.00
|
OD2
|
B:ASP358
|
2.0
|
36.1
|
1.0
|
OD2
|
B:ASP171
|
2.1
|
38.7
|
1.0
|
NE2
|
B:HIS359
|
2.2
|
26.2
|
1.0
|
OG1
|
B:THR209
|
2.2
|
38.9
|
1.0
|
CG
|
B:ASP171
|
2.8
|
36.1
|
1.0
|
OD1
|
B:ASP171
|
2.9
|
37.6
|
1.0
|
CB
|
B:THR209
|
2.9
|
36.5
|
1.0
|
CE1
|
B:HIS359
|
3.0
|
28.0
|
1.0
|
CG
|
B:ASP358
|
3.1
|
31.2
|
1.0
|
CD2
|
B:HIS359
|
3.1
|
26.9
|
1.0
|
CG2
|
B:THR209
|
3.1
|
36.7
|
1.0
|
CA
|
B:THR209
|
3.2
|
36.2
|
1.0
|
OD1
|
B:ASP358
|
3.6
|
34.0
|
1.0
|
N
|
B:THR209
|
3.8
|
36.2
|
1.0
|
C27
|
B:6ZO907
|
4.0
|
61.0
|
1.0
|
ND1
|
B:HIS359
|
4.1
|
27.8
|
1.0
|
CG
|
B:HIS359
|
4.1
|
28.5
|
1.0
|
CB
|
B:ASP171
|
4.2
|
35.1
|
1.0
|
N
|
B:GLY172
|
4.3
|
33.7
|
1.0
|
CB
|
B:ASP358
|
4.3
|
29.4
|
1.0
|
CE1
|
B:HIS474
|
4.4
|
31.1
|
1.0
|
OD1
|
B:ASP311
|
4.4
|
36.2
|
1.0
|
C
|
B:LYS208
|
4.5
|
36.1
|
1.0
|
ZN
|
B:ZN904
|
4.5
|
37.5
|
1.0
|
CA
|
B:ASP171
|
4.5
|
35.0
|
1.0
|
C
|
B:THR209
|
4.5
|
35.9
|
1.0
|
CG
|
B:ASP311
|
4.5
|
38.3
|
1.0
|
NE2
|
B:HIS474
|
4.6
|
29.7
|
1.0
|
C
|
B:ASP171
|
4.8
|
34.5
|
1.0
|
C25
|
B:6ZO907
|
4.8
|
60.7
|
1.0
|
C28
|
B:6ZO907
|
4.8
|
61.8
|
1.0
|
OD2
|
B:ASP311
|
4.8
|
35.4
|
1.0
|
O
|
B:LYS208
|
4.9
|
36.1
|
1.0
|
N31
|
B:6ZO907
|
4.9
|
58.0
|
1.0
|
O
|
B:THR209
|
4.9
|
35.3
|
1.0
|
|
Reference:
S.B.Jones,
L.A.Pfeifer,
T.J.Bleisch,
T.J.Beauchamp,
J.D.Durbin,
V.J.Klimkowski,
N.E.Hughes,
C.J.Rito,
Y.Dao,
J.M.Gruber,
H.Bui,
M.G.Chambers,
S.Chandrasekhar,
C.Lin,
D.J.Mccann,
D.R.Mudra,
J.L.Oskins,
C.A.Swearingen,
K.Thirunavukkarasu,
B.H.Norman.
Novel Autotaxin Inhibitors For the Treatment of Osteoarthritis Pain: Lead Optimization Via Structure-Based Drug Design. Acs Med.Chem.Lett. V. 7 857 2016.
ISSN: ISSN 1948-5875
PubMed: 27660691
DOI: 10.1021/ACSMEDCHEMLETT.6B00207
Page generated: Sun Oct 27 20:44:26 2024
|